GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Raining on the parade even more, Pfizer just reported some good news that seems to confirm the presence of some internal ...

This top pharmaceutical stock was a massive winner in the COVID-19 vaccine sweepstakes but has been beaten down over the past two years as many are not getting boosters. Pfizer Inc. (NYSE: PFE) ...

Heading into Moderna’s third-quarter earnings, investors and analysts will be watching to see how the Cambridge drugmaker ...

Some health experts say Kennedy, even in an informal role, could potentially lead to real consequences for patients, ...

The earnings season for the drug/biotech sector is now in its final lap, with some large biotech and generic drug companies ...

attracting the attention of activist investor Starboard Value - which has questioned Pfizer’s returns from a string of recent ...

Working with mice, hamsters, and nonhuman primates, Penn researchers found that a modified version of the mRNA COVID-19 ...

BioNTech SE (BNTX) reports strong revenue growth and pipeline progress, while navigating financial and legal hurdles.

Revelation: Pfizer’s Dangerous Knowledge About COVID-19 Vaccine Risks** New evidence is surfacing that suggests Pfizer was well aware of serious adverse events linked to its C ...

Lancaster County, Pennsylvania, is in the midst of a significant investigation into suspicious voter registration applications that has revealed a troubling 17% rate of fraudulent submissions.